4//SEC Filing
Frohlich Tom 4
Accession 0001209191-23-006375
CIK 0001435049other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:15 PM ET
Size
14.4 KB
Accession
0001209191-23-006375
Insider Transaction Report
Form 4
Frohlich Tom
Chief Business Officer
Transactions
- Sale
Common Stock
2023-01-31$24.68/sh−4,566$112,700→ 147,674 total - Exercise/Conversion
Restricted Stock Unirt
2023-01-31−8,333→ 16,667 total→ Common Stock (8,333 underlying) - Exercise/Conversion
Common Stock
2023-01-31+8,333→ 152,240 total - Award
Stock Option (Right to Buy)
2023-01-31+84,000→ 84,000 totalExercise: $25.27Exp: 2033-01-30→ Common Stock (84,000 underlying) - Award
Restricted Stock Unit
2023-01-31+21,000→ 21,000 total→ Common Stock (21,000 underlying)
Footnotes (6)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F4]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2023, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date.
- [F5]The stock option vests as to 25% of the total shares on January 31, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F6]The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on January 31, 2024, until fully vested, subject to the reporting person's provision of service to the Issuer on each vesting date.
Documents
Issuer
CHINOOK THERAPEUTICS, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001823925
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 6:15 PM ET
- Size
- 14.4 KB